novel therapy

(University of Pennsylvania School of Medicine) A novel therapy designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced breast cancer patients treated in a small study, researchers report in the July 6 issue of the Lancet.

(University of Montreal) A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer of the Universite de Montreal, has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients.